-
141.发明授权
公开(公告)号：KR101427572B1
公开(公告)日：2014-08-08
申请号：KR1020090114511
申请日：2009-11-25
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 진세노사이드 Re 및 진세노사이드 화합물 K를 함유하는 히알루론산 생성 촉진용 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 인삼 열매 추출물 중 진세노사이드 Re와 인삼 사포닌 대사산물인 진세노사이드 화합물 K(20-O-β-D-글루코피라노실-20(S)-프로토파낙사디올)를 함께 함유하여 인체 세포에서 히알루론산 생성을 촉진시키는 효능이 우수한 피부 외용제 조성물에 관한 것이다.
진세노사이드, 인삼, 사포닌, 히알루론산, 피부 건조 완화, 피부 탄력 증진, 피부 노화 방지-
公开(公告)号：KR1020140049341A
公开(公告)日：2014-04-25
申请号：KR1020120115480
申请日：2012-10-17
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61K36/82 , A61P17/00 , A61K8/97
Abstract: The present invention relates to a composition containing processed extracts, and more specifically, to a composition containing processed ginseng extracts and processed green tea extracts. According to one embodiment of the present invention, the composition includes processed ginseng extracts and processed green tea extracts as an active ingredient. According to another embodiment of the present invention, the composition suppresses and improves skin wrinkles.
Abstract translation: 本发明涉及含有加工提取物的组合物，更具体地说，涉及含有加工的人参提取物和加工的绿茶提取物的组合物。 根据本发明的一个实施方案，组合物包括加工的人参提取物和加工的绿茶提取物作为活性成分。 根据本发明的另一个实施方案，组合物抑制并改善皮肤皱纹。
-
公开(公告)号：KR101382112B1
公开(公告)日：2014-04-09
申请号：KR1020090047317
申请日：2009-05-29
Applicant: (주)아모레퍼시픽 , (주)에이치케이바이오텍
Abstract: 본 발명은 편백다당체를 유효성분으로 함유하는 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 편백다당체를 함유함으로써 콜라겐의 생성을 촉진하여 피부 탄력 및 주름을 개선하고 멜라닌 생성을 억제하여 피부 미백 효과가 뛰어날 뿐만 아니라, 각질 형성 세포 분화를 촉진하여 피부 보습력을 향상시키고 항염증 및 피부 재생 효과가 우수한 피부 외용제 조성물에 관한 것이다.
편백다당체, 항노화, 주름 개선, 탄력 개선, 미백, 보습, 항염증, 피부재생-
公开(公告)号：KR101382113B1
公开(公告)日：2014-04-08
申请号：KR1020090116468
申请日：2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K8/73 , A61K36/258 , A61Q19/08 , A61P17/18
Abstract: 본 발명은 피부 주름 개선, 피부 탄력 증진 및 피부 노화 방지 효과를 갖는 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 분자량이 3만 이상 10만 미만인 백삼 다당체 추출물을 유효성분으로 함유하여, 인간 피부 각질 세포의 미토콘드리아 전자전달계 효소들의 발현을 증가시켜 피부세포의 활성을 향상시킴으로써 피부 주름 개선, 피부 탄력 증진 및 피부 노화 방지 효과를 갖는 피부 외용제 조성물에 관한 것이다.
백삼, 다당체, 분자량, 미토콘드리아 전자전달계 효소, 피부 세포 활성, 피부 주름 개선-
公开(公告)号：KR1020140018725A
公开(公告)日：2014-02-13
申请号：KR1020120085346
申请日：2012-08-03
Applicant: (주)아모레퍼시픽
Abstract: The present invention relates to a composition for preventing hair loss, promoting hair growth, and protecting scalp containing an extract of soybean pods as an effective component. The composition contains 0.001-10 wt% of extract of soybean pods for the total amount of the composition. The composition reduces the stimulation on scalp.
Abstract translation: 本发明涉及一种防止脱发，促进毛发生长，保护含有大豆豆荚提取物的头皮作为有效成分的组合物。 该组合物含有0.001-10重量％的组合物总量的大豆豆荚提取物。 该成分降低对头皮的刺激。
-
Patent Agency Ranking
公开(公告)号：KR1020140017189A
公开(公告)日：2014-02-11
申请号：KR1020120083712
申请日：2012-07-31
Applicant: (주)아모레퍼시픽
Abstract: The present invention relates to a composition for preventing hair loss, promoting hair growth, and protecting scalp which contains an extract of soybean root as an effective component. The composition of the present invention contains 0.001-10 wt% of extract of soybean root for the total amount of the composition.
Abstract translation: 本发明涉及防止脱发，促进毛发生长的组合物，保护含有大豆根提取物的头皮作为有效成分。 本发明的组合物含有0.001-10重量％的组合物总量的大豆根提取物。
-
公开(公告)号：KR1020130141420A
公开(公告)日：2013-12-26
申请号：KR1020130155424
申请日：2013-12-13
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/00 , A61P29/00
Abstract: The present invention relates to a composition for promoting blood circulation including the ginseng fruit extract as an active ingredient, a composition for blood vessel anti-aging, a blood vessel inflammation therapeutic composition, an angiogenesis promoting composition, a composition for treating ischemic heart diseases,a composition for relieving and treating partial blood flow shortage, in particular, and to a composition which includes ginseng fruit extract as an active ingredient to promote the generation of NO, the survival of blood vessel endothelial cell, and to accelerate the vascularization of blood vessel through the portability increment of the blood vessel endothelial cell and blood vessel tube production. [Reference numerals] (AA) Untreated group;(BB) Comparative example 1 100ug/ml;(CC) Example 1 100ug/ml;(DD) Example 2 100ug/ml;(EE) Untreated group;(FF) Untreated group contrast intensity (compared to untreated group %);(GG) Comparative example 1;(HH) Example 1;(II) Example 2
Abstract translation: 本发明涉及一种用于促进血液循环的组合物，包括人参果实提取物作为活性成分，用于血管抗衰老的组合物，血管炎症治疗组合物，促血管生成组合物，用于治疗缺血性心脏病的组合物， 特别是用于缓解和治疗部分血流短缺的组合物，以及包含人参水果提取物作为活性成分的组合物，以促进NO的产生，血管内皮细胞的存活和加速血管的血管化 通过血管内皮细胞和血管管生产的可移植性增加。 （AA）未处理组;（BB）比较例1 100ug / ml;（CC）实施例1 100ug / ml;（DD）实施例2100μg/ ml;（EE）未处理组;（FF） 强度（与未处理组％相比）;（GG）比较例1;（HH）实施例1;（II）实施例2
-
-
公开(公告)号：KR1020130120597A
公开(公告)日：2013-11-05
申请号：KR1020120043617
申请日：2012-04-26
Applicant: (주)아모레퍼시픽
Abstract: The present invention relates to an anti-inflammatory composition containing a soybean extract or a fraction thereof as an active ingredient, particularly, to a composition containing a soybean extract or a faction thereof containing 700 ug/g of dipeptides with anti-inflammation activities. A method for preparing the soybean extract comprises the steps of heating soybeans; fermenting the heated soybeans and flowers; and extracting the fermented soybeans.
Abstract translation: 本发明涉及含有大豆提取物或其部分作为活性成分的抗炎组合物，特别涉及含有700μg/ g具有抗炎活性的二肽的大豆提取物或其组合物的组合物。 制备大豆提取物的方法包括加热大豆的步骤; 发酵加热的大豆和鲜花; 并提取发酵的大豆。
-
150.发明公开
公开(公告)号：KR1020130119212A
公开(公告)日：2013-10-31
申请号：KR1020120042191
申请日：2012-04-23
Applicant: (주)아모레퍼시픽
IPC: A61K31/70 , A61K31/015 , A61K31/01 , A61P17/00
CPC classification number: A61K31/22 , A61K36/82 , A61K2236/19
Abstract: PURPOSE: A composition for antioxidant or whitening effect containing 21-O-angeloyltheasapogenol E3 derived from green tea seed is provided to have an antioxidative effect by inhibition of DPPH and ROS production and an excellent whitening effect due to melanogenesis inhibition and an improvement of pigmentation by ultraviolet rays. CONSTITUTION: A composition for antioxidative skin external application contains 21-O-angeloyltheasapogenol E3 represented by the chemical formula 1 as an active ingredient. Per total weight of the composition, 0.0001-10 weight% of the 21-O-angeloyltheasapogenol E3 is contained. The 21-O-angeloyltheasapogenol E3 is derived from green tea seed. The 21-O-angeloyltheasapogenol E3 is obtained by degrading green tea seed extract using acid, base, enzymes, or microorganism producing the above enzyme.
Abstract translation: 目的：提供含有来源于绿茶种子的21-O-异基因苦参因子E3的抗氧化剂或美白效果的组合物，通过抑制DPPH和ROS产生具有抗氧化作用，并且由于黑素生成抑制和色素沉着改善而具有优异的美白效果 紫外线。 构成：抗氧化皮肤外用组合物含有以化学式1表示的作为活性成分的21-O-神经酰基己内酯E3。 相对于组合物的总重量，含有0.0001-10重量％的21-O-对映异构基因组油E3。 21-O-对甲酰基己内酯E3衍生自绿茶种子。 通过使用产生上述酶的酸，碱，酶或微生物对绿茶种子提取物进行降解获得21-O-异基因苦参皂甙E3。
-
-
-
-
-
-
-
-
-
Search Results
304
records
(took 0.033 seconds)
